Clinical Trial News Archive
Get news by email or subscribe to our news feeds.
News Archive for March 2007
March 1, 2007
- Pharmacopeia to Present Highlights From the Company's DARA Program at the R. Bryan Miller Memorial Symposium
- Genelabs Announces Publication in New England Journal of Medicine of Clinical Trial Results with Hepatitis E Virus Vaccine
- Pluristem Announces Scientific Advance in Stem Cell Research; Evidence That PLX Cells Are Immunosuppressive
- CollaGenex Pharmaceuticals Announces Positive Results of Phase 2 Dose-Finding Study of Incyclinide for the Treatment of Acne
- Lowest FDA-Approved Dosage of Estradiol to Significantly Reduce Hot Flashes Reported in Newly-Published Study
- Affibody Molecules for Cancer Imaging Made by Chemical Synthesis
- Study Published in New England Journal of Medicine: Vaccine 95.5% Effective Against Neglected Hepatitis E
- Excerpt of SEC Filnig by Amgen, Inc.
- AVI BioPharma Presents Novel HIV Drug Candidate Results
- Schizophrenia Drug Studies: One Size Does Not Fit All; Community Services Also Needed
- Lorus Therapeutics Announces a Key Scientific Publication on Therapeutic siRNA in Cancer Therapy
- MAP Pharmaceuticals Reports Positive Phase 2 Results for its Inhaled Migraine Drug Candidate
- New Details in Schizophrenia Treatment Trial Emerge
- New Global Survey Shows Effective Patient-Physician Communication Critical to Accurate and Timely Recognition of Neuropathic Pain
- Idenix Announces Thirteen Data Presentations at the 2007 European Association For the Study of the Liver
- Lorus Therapeutics Announces a Key Scientific Publication on Therapeutic siRNA in Cancer Therapy
- Results with New Integrase Inhibitor Plus Fuzeon and Boosted Protease Inhibitor Show Remarkable Undetectable Rate of 98 Percent in Treatment-Experienced HIV Patients
- Hepatitis Foundation International: New Study Supports Effectiveness of Liver Wellness Education
- Pfizer's Maraviroc, Novel Medicine For HIV, Significantly Reduces Viral Load, in Combination Therapy Across Range of Treatment-Experienced Patients
- New Data on Investigational Agent TMC278 in Anitretroviral-Naive HIV Patients
- New Joslin Study Reveals How a Specific Fat Type Can Protect Against Weight Gain and Diabetes
- Results from Two Phase III Studies on Isentress (raltegravir, MK-0518), Merck's Oral Investigational Integrase Inhibitor Presented at the Annual Conference on Retroviruses and Opportunistic Infections (CROI)
- Monogram Provides Update on Trofile Assay - Pfizer Reports Significant Reduction in Viral Load in Clinical Trial of Maraviroc
March 2, 2007
- Gilead Announces 24-Week Results from Phase II Study of Investigational HIV Integrase Inhibitor GS 9137
- Preclinical Data From Two Novel Idenix Compounds for the Treatment of HIV Presented at Conference on Retroviruses and Opportunistic Infections (CROI)
- Bradley Pharmaceuticals Low-Dose Estrogen Therapy Supported by Recent Medical Literature
- Recent HPV Findings by Centers for Disease Control and Prevention Validate Advaxis, Inc.'s Treatable Population
March 5, 2007
- LAB International Announces Positive Results from the Open-Label Phase IIb Fentanyl Taifun Trial - New Patent Application Submitted
- New Studies Indicate GSK's Pre-Pandemic Influenza Vaccine Can Protect Against Different Strains of H5N1
- Phenomix Completes Phase 2a Clinical Trial - Diabetes Drug is Efficacious and Well Tolerated
- Memory Pharmaceuticals Reports Phase 2a Results for MEM 1003 in Bipolar Disorder
- Transition Therapeutics Announces Positive Data from E1-I.N.T. Clinical Trials in Type 1 and Type 2 Diabetes Patients
- Iomai Vaccine for Travelers' Diarrhea Blunts Severity of Disease in Clinical Study
- Collegium Pharmaceutical Announces Successful Completion of Proof of Concept Clinical Trial for Novel Combination Allergic Rhinitis Product
- Study Shows Nonsurgical Treatment Reduces Neck Pain Without Significant Risk of Paralysis
- Myriad Presents Additional Flurizan Phase 2 Study Data Demonstrating Benefit in Alzheimer's Patients
- Study Examines Genetic Risk Factors for Alzheimer's Disease
- Cytheris Releases Promising Clinical Data on its Interleukin-7 Immune Enhancer at the 2007 CROI Meeting in Los Angeles
- Helix Biopharma to Present L-DOS47 Lung Cancer Research Findings at the Fourth International Conference on Tumor Microenvironment in Florence, Italy
March 6, 2007
- Advanced Magnetics Announces Presentation of Ferumoxytol Data at the National Kidney Foundation 2007 Spring Clinical Meetings
- Replidyne Phase II Pediatric Trial Meets Primary Objective
- POZEN Announces Positive Outcome for PA 325 Proof of Concept Study
- Pozen Announces Positive Outcome for PA 325
- DVT Awareness Survey Findings: Heart and Respiratory Patients
- Nventa Announces Presentation of Positive HspE7 Data from NCI-Sponsored Clinical Trial in Cervical Dysplasia
- AOP Orphan Pharmaceuticals and Lantibio Announce Positive Phase II Study with Novel Cystic Fibrosis Therapy
- Advanced Cell Technology's Ability to Rescue Vision in Blind Rats Noted in Scientific American
March 7, 2007
- CeNeS Pharmaceuticals plc: Update on Successful Phase III results announced on Lead Product M6G
- Actelion Announces Positive Study with Bosentan (Tracleer) in CTEPH
- CV Therapeutics Announces Topline MERLIN TIMI-36 Results
- Acambis Announces Appointment of New Chief Executive Officer and Other Senior Management Changes
- American Society of Clinical Oncology (ASCO) Accepts New Data on AVR118 for Publication in 2007 Abstract Book
- BioLineRx Presents Data on BL-1040 at Cardiovascular Revascularization Therapies Conference Demonstrating Potential to Reduce Deterioration of Infarcted Heart Tissue and Maintain Functionality
- Gemin X Announces Publication of Preclinical Data of GX15-070 in Multiple Myeloma in Blood
- Accentia Biopharmaceuticals Scientific Presentations Demonstrate Increasing Acceptance of Fungal Etiology of Chronic Sinusitis at the Annual Meeting of the American Academy of Allergy, Asthma, and Immunology
- Major Gene Study Uncovers Secrets of Leukemia
- British Journal of Cancer Reports Preclinical Evidence of Positive Effect of Rice Bran on Intestinal Cancer
March 8, 2007
- Hollis-Eden Announces Cancellation of Acute Radiation Syndrome RFP by Department of Health and Human Services
- La Jolla Pharmaceutical Announces Positive Interim Antibody Results From Riquent Lupus Phase 3 Trial
- Arpida adds novel antibiotic AR-2474 to its preclinical pipeline
- Antisoma plc (UK) - Second lung cancer trial adds to positive data on AS1404
- Data From Adherex's European Phase Ib/II Trial of ADH-1 to be Presented at International Symposium on Targeted Anticancer Therapies
- IR BioSciences Announces Data Demonstrating Radilex Stimulation of Stem Cells Results in Hematopoietic Recovery Following Lethal Irradiation
- Newly Released Canadian Data Links Vaccines with Pervasive Developmental Disorder
- Study in Cell by Magen BioSciences Co-Founder David E. Fisher Identifies New Roles in Skin Cancer Prevention for Key Tumor Suppressor Protein
- Weight Management is Not Enough for Cannabinoid Type 1 (CB1) Receptor Antagonists to Become a Commercial Success
- Scottish Scientists Test ‘Secret Weapon’ Against Tumours
- Why Is Polio Spreading in Pakistan?
March 9, 2007
- Vaxiion Researchers Discover Novel Vaccine Delivery System in Collaboration with San Diego State University
- Liponex Inc. Reports Phase I/II Clinical Trial Data for CRD5
- Positive Clinical Data for TASQ - Active Biotech's Novel Treatment of Prostate Cancer
- Nearly 1 in 10 Americans Has A Relative With Kidney Failure
March 12, 2007
- Chemokine Therapeutics Announces Preliminary Results of CTCE-9908 Phase Ib/II Clinical Trial in Late Stage Cancer Patients
- Primary Endpoint Met in Phase 2 Trial of Daclizumab in Patients With Relapsing Multiple Sclerosis
- Preclinical Update - Debio-0512 Therapeutic Vaccine for the Treatment of Chronic and Acute Inflammatory Conditions
- GenoMed Prevents Sickle Cell Pain for Over a Year
- Schering-Plough Announces Presentation of Phase II Trial Results for Novel Oral Thrombin Receptor Antagonist at the 2007 Annual Meeting of The American College of Cardiology/i2 Summit
- Ceragenix Announces Ceragenins Virtually Prevent Catheter Biofilm Formation in 21 Day Study
- Integrated Biopharma's Proprietary Vaccine Technology Achieves Strong Positive Results
- Integrated BioPharma's Proprietary Vaccine Technology Achieves Strong Positive Results
- PI-88 Data to be Presented at Key International Conferences
March 13, 2007
- CeNeRx BioPharma Announces Positive Phase I Results in First Human Trial of Third Generation RIMA Antidepressant
- Framingham Study Shows Parents Who Live Long Pass On Lower Risk of Cardiovascular Disease
- Oncolytics Biotech Inc. Collaborators to Present Reovirus/Gemcitabine Combination Research at AACR Annual Meeting
- Active Biotech's I-3D Micro-dosing Clinical Trial Concluded
- Placebo-controlled Phase IIa Study with the Immunotherapeutic CYT003-QbG10 Shows Significant Improvement of Allergy Symptoms in Hay Fever Patients
- Inflazyme Announces Outcome of Review of Phase 2b Asthma Study: Potential Mitigating Factors Identified which Prevent Clear Interpretation of Results
March 14, 2007
- JACC Publishes Long-Term Safety and Tolerability Data from Ranolazine Open Label Experience (ROLE) Program
- Use of Sequenom's MassARRAY System Leads to Significant Scientific Advances in Understanding Cancer, Diabetes and Drug-Resistant Malaria
- Lev Pharmaceuticals Reports Positive Results in Pivotal Phase III Trial for Hereditary Angioedema
- Tapestry Pharmaceuticals to Present Data on TPI 287 at the 2007 AACR Annual Meeting
- Study of Drug Therapy for Compulsive Buying Yields a Puzzle, Stanford Researcher Says
- Pharmaxis Reports Phase II Results for Aridol in COPD
- AM-Pharma Announces Positive Results of a Phase IIa Clinical Trial with Alkaline Phosphatase in Acute Renal Failure
March 15, 2007
- One-Third of Patients Discontinue Common Breast Cancer Therapy
- Stanford Study Finds No Conclusive Benefit From Treating Kleptomania With Medication
- Intercell AG: Novel tuberculosis Vaccine Shows Promising Immunogenicity and Safety Profile
- DVT Awareness Survey Findings for Respondents in High-Risk Groups: Obese Individuals
- ArQule Announces Acceptance of Clinical Data on ARQ 197, c-Met Inhibitor, for Oral Presentation at ASCO
- The Medicines Company Products Angiomax (bivalirudin) and Cleviprex (clevidipine) Featured in Three Late Breaking Trials at American College of Cardiology Annual Scientific Session
- Researchers Use Poliovirus to Destroy Neuroblastoma Tumors in Mice
March 16, 2007
- Media Advisory: ACC Updated Schedule
- Data from Preclinical Studies of Gilead Nucleotide Compound GS 9219 to be Presented at AACR
March 19, 2007
- Coronary Artery Disease ARISE Trial Showed AGI-1067 Did Not Meet Primary Endpoint
- Acorda Therapeutics Presentation of Fampridine-SR Phase 3 Data Selected for Scientific Highlights Program at the American Academy of Neurology Meeting
- New Phase IV Clinical Study Indicates LidoSite Provides Rheumatology Patients Superior Pain Relief
- Seroquel Sustained Release Schizophrenia Data Presented at ECP Congress in Madrid
- In New Study, Duloxetine Reduced Non-specific Pain and Emotional Symptoms Associated with Depression
- Acadia Announces Positive Results From ACP-103 Phase II Schizophrenia Co-Therapy Trial
- Abbott to Present New Data Across its Vascular Portfolio at the American College of Cardiology's 56th Annual Scientific Session
- AtheroGenics Reports ARISE Trial Results for AGI-1067
- Avid Announces Results of AV-1 Molecular Imaging Agent for Alzheimer's Disease Presented at AD/PD Meeting
- Nymox Announces Positive Results from Newly Completed Long-term Study of NX-1207 for Benign Prostatic Hyperplasia
- Nuvelo Announces Presentation on rNAPc2 at American College of Cardiology 56th Annual Scientific Session
- Medivation Announces Presentation of Full Top-Line Data From Dimebon Six-Month Trial at Major International Alzheimer's Disease Conference
- Amicus Therapeutics Presents Data From Preclinical and Phase 1 Studies of Amigal for Fabry Disease
March 20, 2007
- Calando Pharmaceuticals Publishes the First Non-Human Primate Study on Targeted, Systemic Delivery of siRNA in National Academy of Sciences Journal
- Arrowhead Subsidiary, Calando Pharmaceuticals Publishes Study on Targeted, Systemic Delivery of siRNA
- MGI Pharma Announces Positive Results from a Pivotal Phase 3 Study of Aquavan Injection in Patients Undergoing Bronchoscopy
- La Jolla Pharmaceutical Provides Update on Interim Antibody Results From Riquent Lupus Phase 3 Trial
- Dharma Therapeutics Shows IDDS Is Effective in Reducing Pain Associated With Insertion of an Intravenous Catheter in Their Phase 2 Clinical Trial
- Sunesis Pharmaceuticals Presents SNS-314 Aurora Kinase Inhibitor Data Showing Broad Anti-Tumor Activity, Dosing Flexibility
- ImmuneRegen BioSciences Announces Promising Data on Homspera Suggesting Potential as a Co-Therapeutic Agent
- REACH Registry Demonstrates That Multiple Arterial Disease Locations Sharply Increase the Risk of Major CV Events in Outpatients With Atherothrombosis
- Corcept Therapeutics Announces Phase 3 Study Evaluating Corlux for Psychotic Major Depression Misses Primary Endpoint
- Hospitalization Rates for Coronary Artery Disease Decline in the U.S.
- Avexa Reports Positive Phase IIb Result
- Amicus Therapeutics Presents Preclinical Data from Studies of Plicera for Gaucher Disease
- Alfacell's Onconase Highlighted in Latest Edition of Handbook of Therapeutic Antibodies
- New Data from the US and Japan Support: No Established Causal Link Between Neuropsychiatric Symptoms and Treatment with Tamiflu US Databases Indicate Psychiatric Symptoms Lower in Influenza Patients Taking Tamiflu Versus Those Not Taking Tamiflu
- Researchers Find Surprising Pattern of Influenza Spread in South America and Tropics
- Protein Found to Shield Pancreatic Cancer Cells from Self-Destruction
- Protox Announces Publication in Journal of the National Cancer Institute Supporting PRX302 as Treatment for Prostatic Diseases
March 21, 2007
- The American Liver Foundation Urges Cautious Optimism about CDC Report on Declining Acute Hepatitis Infection Rates
- Amicus Therapeutics Presents Positive Results From Phase 1 Clinical Studies of Plicera for Gaucher Disease
- Alzheimer's Growth Shows Need for Increased FDA Funding
- Medical Journal Publishes First Large-Scale Survey Revealing Experiences of IPF Patients
- Research Results on FluMist Presented at National Association of Pediatric Nurse Practitioners Conference
March 22, 2007
- AEterna Zentaris Reports Positive Results with Cetrorelix in BPH for Japanese Phase 2a Trial
- Isis Pharmaceuticals Announces Its Participation at the Upcoming ACC 56th Annual Scientific Session in New Orleans and Its Live Analyst/Investor Webcast Presentation
- Additional Data From Satraplatin SPARC Phase 3 Trial Presented at European Association of Urology Congress
- Nutra Pharma Announces Publication of Research on Treatment for Multiple Sclerosis
- Aeolus Pharmaceuticals Announces Successful Completion of Multiple Dose Safety Study of AEOL 10150
- Laresse Dermal Filler Research Presented at Anti-Aging World Congress
- Studies Show Mild Hyperthermia Enhances Antitumor Effects of Alfacell's Onconase
- Alnylam and Stanford University Scientists Discover New Role for microRNAs (miRNAs) in T Cell Biology and Immunity
March 23, 2007
- Major Discovery Raises Prospect of Better Patient Care By Improving Platelet Life Span
- Sarasota's Roskamp Institute Announces Positive Safety Data in Human Clinical Study for Alzheimer's Disease
- ZIOPHARM Presents ZIO-201 Lymphoma Data at ISH
- Leukemic Cells Find Safe Haven in Bone Marrow
- Metabasis Therapeutics to Present Poster at American Association for Cancer Research
- Viral Enzyme Recruited in Fight Against Ear Infection
- MUSC Research Offers Hope for Those Resistant to Depression Treatment
- Study Shows Metabolic Strategy of Stressed Cell
March 26, 2007
- Abbott's Xience V Everolimus Eluting Coronary Stent Superior to Taxus Stent in Spirit III U.S. Pivotal Clinical Trial
- New Clinical Data for Cytogen's Quadramet and Prostacint to be Reported at Upcoming Major Medical Meetings
- EntreMed Presents Mechanism Data for Its Three Lead Oncology Compounds
- First Study To Show Positive Benefit On Atherosclerosis For People With Early Signs Of Diseased Arteries
- Abbott Announces Positive Six-Month Results From the World's First Clinical Trial of a Fully Bioabsorbable Drug-Eluting Coronary Stent
- Inovio Biomedical's DNA Delivery Technology Significantly Enhances Potency of HIV DNA Vaccine
- Inimex Product Candidate is First Immune Defense Regulator to Cure Infections Without Causing Harmful Inflammation
- In vivo Study Results Demonstrating Potential of Alfacell's Onconase for Treatment of Non-Small Cell Lung Cancer Published in Anticancer Research
- Everest Data on Short- and Long-Term Use of Otsuka's Investigational Novel Treatment, Tolvaptan, Published in Journal of the American Medical Association and Featured in ACC's Late Breaking Clinical Trials
- Scios Announces Results From Exploratory Nesiritide Study Providing Important New Renal and Mortality Safety Data with a Neutral Effect on the Primary Endpoint
- Cholesterol Drug Fails to Slow Progression of Coronary Disease, Cleveland Clinic Study Reports
- Study Presented at the ACC Shows Inflammatory Enzyme Lp-PLA2 Predicts Heart Disease Risk in Metabolic Syndrome Patients
- Tekturna, First New Type of High Blood Pressure Medicine in a Decade, Provides Additional Blood Pressure Reduction When Used With Diovan
- Isis Pharmaceuticals Reports Positive Phase 2 Data for ISIS 301012 in Familial Hypercholesterolemia Patients Presented at ACC
- Diobex Announces Successful Completion of Phase 2a Trial Of DIO-902, a Novel Cortisol Synthesis Inhibitor for Type 2 Diabetes
- Study: Identical Doses of BiDil Components Are Not Bioequivalent to the Fixed Dose Combination-BiDil-Used in A-HeFT
- Two New Imaging Studies Show Higher Dose Lipitor Stopped the Progression of Atherosclerosis
- Cypher Sirolimus-eluting Coronary Stent Had Similar Results to Bypass Surgery in Long-Term Study of Patients With Multi-Vessel Coronary Artery Disease
- Two-Year Results from the Medtronic ENDEAVOR III Trial Confirm Stent's Positive Clinical Profile
- CSL Therapy That Mimics 'Good' Cholesterol May Reduce Plaque Volume in Coronary Arteries
- Two Abbott Studies Reaffirm Carotid Artery Stenting as a Safe and Effective Treatment to Reduce Risk of Stroke
- Alexza's AZ-004 Phase IIa Trial Meets Primary Endpoint in Treating Schizophrenic Patients With Acute Agitation
- Two-Year Patient Registry Results Support Safety and Efficacy of Cypher Sirolimus-Eluting Coronary Stent in 'Real World' Uses
- Acuity One-Year Findings Meet All Primary Endpoints in Favor of Angiomax (Bivalirudin) Alone Treatment Group
- Calcium Plaque Build-up in the Arteries Leads to Coronary Heart Disease in Multi-Ethnic Groups
March 27, 2007
- Rigel Ubiquitin Ligase Program Identifies Molecules With Anti-HIV Activity
- Afid Therapeutics Obtains Positive Evaluation of its Triple Mode Viral Sequestration Agents
- Landmark Findings From ECLIPSE Program Show Improved Control of Perioperative Hypertension Reduces Risk of Death In Cardiac Surgery
- Positive Interim Phase 2 Data Reported for VEGF Trap-Eye in Age-Related Macular Degeneration
- Study Presented at ACC Shows Treatment With ISIS 301012 Added to Statins for Only 5 Weeks Results in 75% of Patients Achieving LDL-C Levels Less Than 100 mg/dL and 50% of Patients Achieving LDL-C Levels of Less Than 70 mg/dL
- MediciNova Announces Positive Clinical Results From MN-166 Phase II Multiple Sclerosis Trial
- Lipitor Provides Unprecedented Cardiovascular Risk Reductions in Diabetes Patients with Metabolic Syndrome and in Stroke Patients
- PC-DAC:Exendin-4 Phase I/II Multiple-Dose Study Preliminary Results Demonstrate Safety and Efficacy at Once-Weekly Dosing
- CombinatoRx Provides Topline Results from Phase 2 RA Study with CRx-139 and Very Low Dose Prednisolone
- Survey Reveals Significant Public Lack of Diabetes Awareness
- Curecumin May Be an Effective Treatment for Lung Cancer
- Interferon Beta DNA Treatment Delivered with Ichor Technology Reduces Atherosclerosis Progression in Mice
- Isotechnika's independent data monitoring committee conducts review of phase 2b kidney transplant trial
- Pivotal Phase III Findings With Investigational Drug Cleviprex (Clevidipine) Demonstrate Perioperative Blood Pressure Control In Cardiac Surgery
- Lipitor Significantly Lowered Hospitalization Costs for Patients with Heart Disease, Two New Analyses Show
- Inotek Pharmaceuticals Announces Presentation of Phase 2 Clinical Data for INO-1001 at ACC Demonstrating PARP Inhibition and Anti-inflammatory Activity in Plasma of Patients Undergoing Primary Percutaneous Coronary Intervention
- Heart Attack Patients Treated With Novel Stem Cell Therapy Experience Significant Improvement in Heart and Lung Function
- Increasing Proportion of Cardiovascular Disease Due to Diabetes Over the Last 50 Years
March 28, 2007
- ACC Presentation Indicates Interleukin-1 Gene Variants Determine Increased Risk for Coronary Artery Disease from Oxidized Phospholipids
- Ace Biosciences, Ace393, the World's First Commercial Vaccine for Travellers' Diarrhoea Caused by Campylobacter Successfully Completes Phase I Clinical Trials
- Calcium Channel Blocker Adalat GITS Offer Additional Benefits
- CSL Therapy That Mimics “Good” Cholesterol May Reduce Plaque Volume in Coronary Arteries
- Biosite Reports on Presentation of Preliminary Data From Sepsis Program
- CeNeS Pharmaceuticals Plc Announces Preliminary Results for The Year Ending 31 December 2006
- Diabetes Linked to Higher Parkinson's Risk
- Dong-A PharmTech Co., Ltd. Announces Positive Results for Udenafil, Its New Long Acting Drug For Erectile Dysfunction
- MRI Detects Cancers in the Opposite Breast of Women Newly Diagnosed with Breast Cancer
- New Study Confirms Role for Pertussis Immunization of Entire Family in Reducing Infant Pertussis
March 29, 2007
- Preclinical Data on Cytogen's Technology to be Reported at the AACR Annual Meeting
- Arpida Announces Promising Results of "First-In-Man" Studies With AR-709
- Emisphere Technologies, Inc. Reports Clinical Data on Oral Delivery of GLP-1 and PYY
- Anthrax Monoclonal Antibody Valortim Demonstrates Therapeutic Effect in New Primate Model of Established Anthrax Infection
- Pieris Demonstrates Potent Anti-Tumor Activity of a VEGF-Specific Anticalin in Preclinical Studies
- Baxter Announces Final Phase I/II Data and Initiation of Phase III Clinical Trial for Candidate Pandemic H5N1 Influenza Vaccine
- ADVENTRX to Present CoFactor Multiagent Therapy Data at AACR Annual Meeting
- Portola Pharmaceuticals Presents Positive Phase I Data of Its ADP Receptor Antagonist at the American College of Cardiology
- Orapred ODT Tastes Good
- Mymetics' HIV Vaccine Achieves Research Breakthrough, Eliciting Protective Antibody Response in Mucosal Tissues of Non-Human Primate Model
- ACADIA Pharmaceuticals' Schizophrenia Programs to Be Presented at the 2007 International Congress on Schizophrenia Research
- Study Sheds Light on Medication Treatment Options for Bipolar Disorder
- Anthrax Monoclonal Antibody Valortim(tm) Demonstrates Therapeutic Effect in New Primate Model of Established Anthrax Infection
March 30, 2007
- Safety Analyses of Clinical Data for Bifeprunox in Patients with Schizophrenia Showed a Favorable Weight and Lipid Profile, Similar to Placebo
- Presentations at American College of Cardiology Meeting Highlight New Opportunities for HDL Therapy
- Study Suggests Invega Helps Patients With Schizophrenia Maintain Symptom Control
